Table: Delta-Fly Pharma - Q1 parent results

Delta-Fly Pharma

14/08/2019 05:00

Aug 14 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to   
                Jun 30, 2019        Jun 30, 2018       Mar 31, 2020  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Operating     loss 216 mln        loss 105 mln        loss 1.07    
  Recurring     loss 218 mln        loss 104 mln        loss 1.07    
  Net           loss 219 mln        loss 105 mln        loss 1.07    
  EPS          loss 50.15 yen      loss 29.25 yen    loss 244.85 yen 
  Ann Div                                NIL               NIL       
  -Q2 div                                NIL               NIL       
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T